Apelin Controls Fetal and Neonatal Glucose Homeostasis and Is Altered by Maternal Undernutrition

Diabetes. 2016 Mar;65(3):554-60. doi: 10.2337/db15-0228. Epub 2015 Dec 2.

Abstract

The adequate control of glucose homeostasis during both gestation and early postnatal life is crucial for the development of the fetoplacental unit and adaptive physiological responses at birth. Growing evidences indicate that apelin and its receptor, APJ, which are expressed across a wide range of tissues, exert important roles in glucose homeostasis in adults. However, little is known about the function of the apelinergic system during gestation. In this study, we evaluated the activity of this system in rats, the role of apelin in fetal and neonatal glucose homeostasis, and its modulation by maternal food restriction. We found that 1) the apelinergic system was expressed at the fetoplacental interface and in numerous fetal tissues, 2) ex vivo, the placenta released high amounts of apelin in late gestation, 3) intravenous apelin injection in mothers increased the transplacental transport of glucose, and 4) intraperitoneal apelin administration in neonates increased glucose uptake in lung and muscle. Maternal food restriction drastically reduced apelinemia in both mothers and growth-restricted fetuses and altered the expression of the apelinergic system at the fetoplacental interface. Together, our data demonstrate that apelin controls fetal and neonatal glucose homeostasis and is altered by fetal growth restriction induced by maternal undernutrition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Apelin
  • Apelin Receptors
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fetal Growth Retardation / genetics*
  • Fetal Growth Retardation / metabolism
  • Fetus / metabolism*
  • Gene Expression Regulation, Developmental
  • Glucose Transporter Type 1 / genetics
  • Glucose Transporter Type 3 / genetics
  • Homeostasis / drug effects
  • Insulin / metabolism
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Lung / drug effects
  • Lung / metabolism
  • Malnutrition / metabolism*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Placenta / metabolism
  • Pregnancy
  • Pregnancy Complications / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, G-Protein-Coupled / genetics
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Apelin
  • Apelin Receptors
  • Apln protein, rat
  • Aplnr protein, rat
  • Blood Glucose
  • Glucose Transporter Type 1
  • Glucose Transporter Type 3
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Receptors, G-Protein-Coupled
  • Slc2a1 protein, rat
  • Slc2a3 protein, rat
  • apelin 13, Pyr(1)-